GABAPENTIN tablet, film coated

Land: USA

Språk: engelska

Källa: NLM (National Library of Medicine)

Köp det nu

Ladda ner Bipacksedel (PIL)
01-11-2019
Ladda ner Produktens egenskaper (SPC)
01-11-2019

Aktiva substanser:

GABAPENTIN (UNII: 6CW7F3G59X) (GABAPENTIN - UNII:6CW7F3G59X)

Tillgänglig från:

Proficient Rx

INN (International namn):

GABAPENTIN

Sammansättning:

GABAPENTIN 600 mg

Administreringssätt:

ORAL

Receptbelagda typ:

PRESCRIPTION DRUG

Terapeutiska indikationer:

Gabapentin is indicated for the management of postherpetic neuralgia in adults. Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy.  Gabapentin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years. Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. Gabapentin is not a scheduled drug. Gabapentin does not exhibit affinity for benzodiazepine, opiate (mu, delta or kappa), or cannabinoid 1 receptor sites. A small number of postmarketing cases report gabapentin misuse and abuse. These individuals were taking higher than recommended doses of gabapentin for unapproved uses. Most of the individuals described in these reports had a history of poly-substance abuse or used gabapentin to relieve symptoms of withdrawal from other substances. When prescribing gabapentin carefully e

Produktsammanfattning:

Gabapentin Tablets, USP are supplied as follows: 600 mg — Each light green, capsule shaped, film coated tablet imprinted with and 636 on one side and bisected on the other side contains 600 mg of gabapentin, USP. Tablets are supplied in bottles of 90 with a child-resistant closure (NDC 63187-006-90). Dispense in a tight, light-resistant container as defined in the USP. Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. Maalox® is a registered trademark of Novartis Consumer Health, Inc. Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue Elizabeth, NJ 07207 USA Repackaged by: Proficient Rx Westlake Village, CA 91362

Bemyndigande status:

Abbreviated New Drug Application

Bipacksedel

                                GABAPENTIN- GABAPENTIN TABLET, FILM COATED
Proficient Rx
----------
MEDICATION GUIDE
GABAPENTIN TABLETS, USP
Rx only
Read the Medication Guide before you start taking gabapentin and each
time you get a refill. There may
be new information. This information does not take the place of
talking to your healthcare provider about
your medical condition or treatment.
What is the most important information I should know about gabapentin?
Do not stop taking gabapentin without first talking to your healthcare
provider.
Stopping gabapentin suddenly can cause serious problems.
Gabapentin can cause serious side effects including:
1. Like other antiepileptic drugs, gabapentin may cause suicidal
thoughts or actions in a very small
number of people, about 1 in 500.
Call a healthcare provider right away if you have any of these
symptoms, especially if they are new,
worse, or worry you:
•
thoughts about suicide or dying
•
attempts to commit suicide
•
new or worse depression
•
new or worse anxiety
•
feeling agitated or restless
•
panic attacks
•
trouble sleeping (insomnia)
•
new or worse irritability
•
acting aggressive, being angry, or violent
•
acting on dangerous impulses
•
an extreme increase in activity and talking (mania)
•
other unusual changes in behavior or mood
How can I watch for early symptoms of suicidal thoughts and actions?
•
Pay attention to any changes, especially sudden changes, in mood,
behaviors, thoughts, or feelings.
•
Keep all follow-up visits with your healthcare provider as scheduled.
Call your healthcare provider between visits as needed, especially if
you are worried about symptoms.
Do not stop taking gabapentin without first talking to a healthcare
provider.
•
Stopping gabapentin suddenly can cause serious problems. Stopping a
seizure medicine suddenly in
a patient who has epilepsy can cause seizures that will not stop
(status epilepticus).
Suicidal thoughts or actions can be caused by things other than
medicines. If you have suicidal
thoughts or actions, your healthcare pro
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                GABAPENTIN- GABAPENTIN TABLET, FILM COATED
PROFICIENT RX
----------
GABAPENTIN TABLETS, USP
40-9159
Revised — May 2013
RX ONLY
DESCRIPTION
Gabapentin tablets, USP are supplied as elliptical film-coated tablets
containing 600 mg and 800 mg of
gabapentin, USP.
The inactive ingredients are: calcium stearate, crospovidone,
hydroxypropyl cellulose, hypromellose,
polyethylene glycol and titanium dioxide. The 600 mg tablet also
contains FD&C blue #2 aluminum lake
and synthetic yellow iron oxide. The 800 mg tablet also contains
synthetic black iron oxide.
Gabapentin, USP is described as 1-(aminomethyl) cyclohexaneacetic acid
with a molecular formula of
C H NO and a molecular weight of 171.24. The structural formula of
gabapentin is:
Gabapentin is a white to off-white crystalline solid with a pK of 3.7
and a pK of 10.7. It is freely
soluble in water and both basic and acidic aqueous solutions. The log
of the partition coefficient (n-
octanol/0.05M phosphate buffer) at pH 7.4 is -1.25.
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION
The mechanism by which gabapentin exerts its analgesic action is
unknown, but in animal models of
analgesia, gabapentin prevents allodynia (pain-related behavior in
response to a normally innocuous
stimulus) and hyperalgesia (exaggerated response to painful stimuli).
In particular, gabapentin prevents
pain-related responses in several models of neuropathic pain in rats
or mice (e.g., spinal nerve ligation
models, streptozocin-induced diabetes model, spinal cord injury model,
acute herpes zoster infection
model). Gabapentin also decreases pain-related responses after
peripheral inflammation (carrageenan
footpad test, late phase of formalin test). Gabapentin did not alter
immediate pain-related behaviors (rat
tail flick test, formalin footpad acute phase, acetic acid abdominal
constriction test, footpad heat
irradiation test). The relevance of these models to human pain is not
known.
The mechanism by which gabapentin exerts its anticonvulsant action is
unknown, but in animal test
systems designed to 
                                
                                Läs hela dokumentet
                                
                            

Sök varningar relaterade till denna produkt